glutathione s transferases and drug resistance Frontiers ciel quantity:1 New in the August

glutathione s transferases and drug resistance Frontiers ciel quantity:1 New in the August

New in the August 14, 2025, issue of NEJM: Cagrilintide–Semaglutide for Overweight or Obesity (REDEFINE 1 phase 3a trial) https://nej.md/444aW7f Cagrilintide–Semaglutide for Overweight and Diabetes (REDEFINE 2 phase 3a trial) https://nej.md/4ehQwLk ...

This narrative review aims to provide insight into the existing and emerging pharmacological treatment options for the management of PD, while highlighting the need for innovative strategies to improve outcomes for individuals living with PD, comparing the benefits versus risks

ciel

quantity:1

Se status affects the immune response to parasitic infections